Found: 62
Select item for more details and to access through your institution.
The Current Status of Camptothecin Analogues as Antitumor Agents.
- Published in:
- JNCI: Journal of the National Cancer Institute, 1993, v. 85, n. 4, p. 271, doi. 10.1093/jnci/85.4.271
- By:
- Publication type:
- Article
The elephant and the blind men: making sense of PARP inhibitors in homologous recombination deficient tumor cells.
- Published in:
- Frontiers in Oncology, 2013, v. 3, p. 1, doi. 10.3389/fonc.2013.00228
- By:
- Publication type:
- Article
Caspase-6 gene disruption reveals a requirement for lamin A cleavage in apoptotic chromatin condensation.
- Published in:
- EMBO Journal, 2002, v. 21, n. 8, p. 1967, doi. 10.1093/emboj/21.8.1967
- By:
- Publication type:
- Article
Deficiencies in Chfr and Mlh1 synergistically enhance tumor susceptibility in mice.
- Published in:
- 2009
- By:
- Publication type:
- journal article
Deficiencies in Chfr and Mlh1 synergistically enhance tumor susceptibility in mice.
- Published in:
- Journal of Clinical Investigation, 2009, v. 119, n. 9, p. 2714
- By:
- Publication type:
- Article
Anticancer therapy: boosting the bang of Bim.
- Published in:
- 2008
- By:
- Publication type:
- journal article
Serine protease HtrA1 modulates chemotherapy-induced cytotoxicity.
- Published in:
- Journal of Clinical Investigation, 2006, v. 116, n. 7, p. 1994, doi. 10.1172/JCI27698
- By:
- Publication type:
- Article
Assessment of Drug Sensitivity in Hematopoietic Stem and Progenitor Cells from Acute Myelogenous Leukemia and Myelodysplastic Syndrome Ex Vivo.
- Published in:
- Stem Cells Translational Medicine, 2017, v. 6, n. 3, p. 840, doi. 10.5966/sctm.2016-0034
- By:
- Publication type:
- Article
Diagnostic and prognostic potential of the microbiome in ovarian cancer treatment response.
- Published in:
- Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-27555-x
- By:
- Publication type:
- Article
Spartan deficiency causes accumulation of Topoisomerase 1 cleavage complexes and tumorigenesis.
- Published in:
- Nucleic Acids Research, 2017, v. 45, n. 8, p. 4564, doi. 10.1093/nar/gkx107
- By:
- Publication type:
- Article
Immunodetection of human topoisomerase I-DNA covalent complexes.
- Published in:
- Nucleic Acids Research, 2016, v. 44, n. 6, p. 2816, doi. 10.1093/nar/gkw109
- By:
- Publication type:
- Article
Decreased drug accumulation in a mitoxantrone-resistant gastric carcinoma cell line in the absence of P-glycoprotein.
- Published in:
- International Journal of Cancer, 1997, v. 71, n. 5, p. 817, doi. 10.1002/(SICI)1097-0215(19970529)71:5<817::AID-IJC20>3.0.CO;2-3
- By:
- Publication type:
- Article
Phase 1 trial of navitoclax and sorafenib in patients with relapsed or refractory solid tumors with hepatocellular carcinoma expansion cohort.
- Published in:
- Investigational New Drugs, 2024, v. 42, n. 1, p. 127, doi. 10.1007/s10637-024-01420-8
- By:
- Publication type:
- Article
A phase I study of the farnesyltransferase inhibitor Tipifarnib in combination with the epidermal growth factor tyrosine kinase inhibitor Erlotinib in patients with advanced solid tumors.
- Published in:
- Investigational New Drugs, 2019, v. 37, n. 2, p. 307, doi. 10.1007/s10637-018-0662-1
- By:
- Publication type:
- Article
Noxa mediates hepatic stellate cell apoptosis by proteasome inhibition.
- Published in:
- Hepatology Research, 2010, v. 40, n. 7, p. 701, doi. 10.1111/j.1872-034X.2010.00668.x
- By:
- Publication type:
- Article
Factors Affecting Topotecan Sensitivity in Human Leukemia Samples<sup>a</sup>.
- Published in:
- Annals of the New York Academy of Sciences, 1996, v. 803, n. 1, p. 128, doi. 10.1111/j.1749-6632.1996.tb26382.x
- By:
- Publication type:
- Article
Cytotoxic effects of topotecan combined with various anticancer agents in human cancer cell lines.
- Published in:
- JNCI: Journal of the National Cancer Institute, 1996, v. 88, n. 11, p. 734, doi. 10.1093/jnci/88.11.734
- By:
- Publication type:
- Article
The role of Mcl-1 downregulation in the proapoptotic activity of the multikinase inhibitor BAY 43-9006.
- Published in:
- Oncogene, 2005, v. 24, n. 46, p. 6861, doi. 10.1038/sj.onc.1208841
- By:
- Publication type:
- Article
Epigenetic silencing of TCEAL7 (Bex4) in ovarian cancer.
- Published in:
- Oncogene, 2005, v. 24, n. 32, p. 5089, doi. 10.1038/sj.onc.1208700
- By:
- Publication type:
- Article
A candidate tumor suppressor HtrA1 is downregulated in ovarian cancer.
- Published in:
- Oncogene, 2004, v. 23, n. 8, p. 1636, doi. 10.1038/sj.onc.1207271
- By:
- Publication type:
- Article
Alterations in the apoptotic machinery and their potential role in anticancer drug resistance.
- Published in:
- Oncogene, 2003, v. 22, n. 47, p. 7414, doi. 10.1038/sj.onc.1206945
- By:
- Publication type:
- Article
ZC3H18 specifically binds and activates the BRCA1 promoter to facilitate homologous recombination in ovarian cancer.
- Published in:
- Nature Communications, 2019, v. 10, n. 1, p. N.PAG, doi. 10.1038/s41467-019-12610-x
- By:
- Publication type:
- Article
PARP Inhibitors and Myeloid Neoplasms: A Double-Edged Sword.
- Published in:
- Cancers, 2021, v. 13, n. 24, p. 6385, doi. 10.3390/cancers13246385
- By:
- Publication type:
- Article
CHFR and Paclitaxel Sensitivity of Ovarian Cancer.
- Published in:
- Cancers, 2021, v. 13, n. 23, p. 6043, doi. 10.3390/cancers13236043
- By:
- Publication type:
- Article
A phase 2 and pharmacological study of sapanisertib in patients with relapsed and/or refractory acute lymphoblastic leukemia.
- Published in:
- Cancer Medicine, 2023, v. 12, n. 23, p. 21229, doi. 10.1002/cam4.6701
- By:
- Publication type:
- Article
Apoptosis in cancer: cause and cure.
- Published in:
- BioEssays, 2000, v. 22, n. 11, p. 1007, doi. 10.1002/1521-1878(200011)22:11<1007::AID-BIES7>3.0.CO;2-4
- By:
- Publication type:
- Article
Therapy-related acute promyelocytic leukemia: observations relating to APL pathogenesis and therapy.
- Published in:
- European Journal of Haematology, 2012, v. 88, n. 3, p. 237, doi. 10.1111/j.1600-0609.2011.01727.x
- By:
- Publication type:
- Article
Low-dose, single-agent temsirolimus for relapsed mantle cell lymphoma: a phase 2 trial in the North Central Cancer Treatment Group.
- Published in:
- 2008
- By:
- Publication type:
- journal article
Irinotecan in the treatment of glioma patients: current and future studies of the North Central Cancer Treatment Group.
- Published in:
- 2003
- By:
- Publication type:
- journal article
Irinotecan in the treatment of glioma patients (These studies are being conducted as a collaborative effort of the North Central Cancer Treatment Group, Mayo Clinic, and Pharmacia Corporation.).
- Published in:
- Cancer (0008543X), 2003, v. 97, p. 2352
- By:
- Publication type:
- Article
Racial and ethnic differences in epithelial ovarian cancer risk: an analysis from the Ovarian Cancer Association Consortium.
- Published in:
- American Journal of Epidemiology, 2024, v. 193, n. 9, p. 1242, doi. 10.1093/aje/kwae076
- By:
- Publication type:
- Article
Osteoblasts Protect AML Cells From SDF-1-Induced Apoptosis.
- Published in:
- Journal of Cellular Biochemistry, 2014, v. 115, n. 6, p. 1128, doi. 10.1002/jcb.24755
- By:
- Publication type:
- Article
The Impact of Obesity on the Outcomes of Adult Patients with Acute Lymphoblastic Leukemia – A Single Center Retrospective Study.
- Published in:
- Blood & Lymphatic Cancer: Targets & Therapy, 2021, v. 11, p. 1, doi. 10.2147/BLCTT.S269748
- By:
- Publication type:
- Article
A cell cycle-dependent BRCA1-UHRF1 cascade regulates DNA double-strand break repair pathway choice.
- Published in:
- Nature Communications, 2016, v. 7, n. 1, p. 10201, doi. 10.1038/ncomms10201
- By:
- Publication type:
- Article
Transient binding of an activator BH3 domain to the Bak BH3-binding groove initiates Bak oligomerization.
- Published in:
- Journal of Cell Biology, 2011, v. 194, n. 1, p. 39, doi. 10.1083/jcb.201102027
- By:
- Publication type:
- Article
Transient binding of an activator BH3 domain to the Bak BH3-binding groove initiates Bak oligomerization.
- Published in:
- Journal of Cell Biology, 2011, v. 193, n. 8, p. 39, doi. 10.1083/jcb.201102027
- By:
- Publication type:
- Article
Relationship between BCL2 mutations and follicular lymphoma outcome in the chemoimmunotherapy era.
- Published in:
- Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00847-1
- By:
- Publication type:
- Article
Relationship between BCL2 mutations and follicular lymphoma outcome in the chemoimmunotherapy era.
- Published in:
- Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00847-1
- By:
- Publication type:
- Article
Statistical analysis of comparative tumor growth repeated measures experiments in the ovarian cancer patient derived xenograft (PDX) setting.
- Published in:
- Scientific Reports, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41598-021-87470-x
- By:
- Publication type:
- Article
Eltrombopag directly activates BAK and induces apoptosis.
- Published in:
- Cell Death & Disease, 2023, v. 14, n. 7, p. 1, doi. 10.1038/s41419-023-05918-6
- By:
- Publication type:
- Article
Fatty acid synthase (FASN) regulates the mitochondrial priming of cancer cells.
- Published in:
- Cell Death & Disease, 2021, v. 12, n. 11, p. 1, doi. 10.1038/s41419-021-04262-x
- By:
- Publication type:
- Article
Correction: Constitutive BAK/MCL1 complexes predict paclitaxel and S63845 sensitivity of ovarian cancer.
- Published in:
- 2021
- By:
- Publication type:
- Correction Notice
Constitutive BAK/MCL1 complexes predict paclitaxel and S63845 sensitivity of ovarian cancer.
- Published in:
- Cell Death & Disease, 2021, v. 12, n. 8, p. 1, doi. 10.1038/s41419-021-04073-0
- By:
- Publication type:
- Article
A randomized trial of three novel regimens for recurrent acute myeloid leukemia demonstrates the continuing challenge of treating this difficult disease.
- Published in:
- American Journal of Hematology, 2019, v. 94, n. 1, p. 111, doi. 10.1002/ajh.25333
- By:
- Publication type:
- Article
Durable molecular remissions with a single cycle of timed sequential consolidation chemotherapy in acute promyelocytic leukemia.
- Published in:
- American Journal of Hematology, 2005, v. 79, n. 2, p. 119, doi. 10.1002/ajh.20354
- By:
- Publication type:
- Article
Porphyromonas somerae Invasion of Endometrial Cancer Cells.
- Published in:
- Frontiers in Microbiology, 2021, v. 12, p. 1, doi. 10.3389/fmicb.2021.674835
- By:
- Publication type:
- Article
ZNF432 stimulates PARylation and inhibits DNA resection to balance PARPi sensitivity and resistance.
- Published in:
- Nucleic Acids Research, 2023, v. 51, n. 20, p. 11056, doi. 10.1093/nar/gkad791
- By:
- Publication type:
- Article
Methylation of all BRCA1 copies predicts response to the PARP inhibitor rucaparib in ovarian carcinoma.
- Published in:
- Nature Communications, 2018, v. 9, n. 1, p. 1, doi. 10.1038/s41467-018-05564-z
- By:
- Publication type:
- Article
Circulating CD14<sup>+</sup>HLA‐DR<sup>lo/−</sup> monocytic cells as a biomarker for epithelial ovarian cancer progression.
- Published in:
- American Journal of Reproductive Immunology, 2021, v. 85, n. 3, p. 1, doi. 10.1111/aji.13343
- By:
- Publication type:
- Article
Long-term survival of an ovarian cancer patient harboring a RAD51C missense mutation.
- Published in:
- Cold Spring Harbor Molecular Case Studies, 2021, v. 7, n. 2, p. 1, doi. 10.1101/mcs.a006083
- By:
- Publication type:
- Article